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1. Introduction
There is now widespread evidence for vesicular
transfer of proteins between membrane compartments
on the endocytic and exocytic pathways of eukaryotic
cells. Vesicles bud from one organelle and deliver
their contents to an appropriate acceptor compartment
by a specific docking and membrane fusion event. To
ensure the fidelity and vectoriality of transport, each
transport step is coupled to nucleotide hydrolysis via
an ordered and regulated biochemical pathway. In
particular, fusion between transport vesicle and target
membrane requires recruitment of an array of mem-
brane-associated and cytosolic proteins to the point of
vesicle docking. This review will describe the central
role in this process played by the NEM-Sensitive
 .Fusion protein NSF and associated factors.
2. N-Ethylmaleimide-Sensitive Fusion protein
( )NSF
The role of NSF in vesicular transport was first
discovered by the seminal work of Rothman and
colleagues, who constructed a biochemical assay to
measure vesicular transport between successive cis-
w xternae of the Golgi complex in vitro 1 . Transport
was blocked when incubations were pretreated with
 . w xthe alkylating agent N-ethylmaleimide NEM 2 .
Morphological examination indicated the most likely
point of inhibition was during the attachment or
fusion of transport vesicles with the target membrane
w x3 . After removal of the alkylating agent, transport
activity was restored by addition of fresh Golgi mem-
brane or cytosolic fractions, indicating the presence
 .of NEM-sensitive factor s required for docking
andror fusion that could cycle between membrane-
w xbound and cytosolic forms 2 . Reconstitution of
w xtransport activity enabled the purification of NSF 4 .
NSF plays a central role in many, but not all,
vesicular transport pathways in addition to intra-Golgi
transport. It is required in mammalian cells for trans-
w xport from the ER to the Golgi complex 5 , as well as
w xfor fusion in vitro between endosomal vesicles 6,7 .
It is also required for transport of newly synthesised
w xproteins to the basolateral plasma membrane 8 and
for delivery of transcytotic vesicles to the apical
w xplasma membrane in polarised cells 9 . NSF is highly
conserved; the budding yeast secretory mutant sec18
encodes a protein homologous to mammalian NSF
w x w x10 which can substitute for NSF activity 11 . Sec18
 .protein p requirement has been demonstrated at ev-
w xery step of the secretory pathway in yeast 12 , and is
w xalso implicated in the endocytic pathway 13 . More
recently, two closely related NSF homologues have
w xbeen described in Drosophila 14,15 . Indeed, a tem-
perature-sensitive Drosophila mutant comatose,
which exhibits a severe defect in synaptic transmis-
sion, has been mapped to a point mutation in the
w xdNSF1 gene 16 .
NSF is a hydrophilic 76 kDa protein which forms
a homooligomer and is stabilised by adenine nu-
w xcleotides 4,17 . Although sedimentation analysis is
consistent with a trimeric complex, recent microscop-
ical studies show that the protein forms a hexamer
w x18 . Intriguingly, the overall structure of the oligomer
w xis an asymmetric barrel with a central pore 19 . Each
polypeptide chain is organised into an N terminal
 .domain a.a. 1–205 , followed by two closely related
 .domains D1; a.a. 206–477 and D2; a.a. 478–744 ,
both of which contain classical Walker motifs for
w x  .ATP binding and hydrolysis 17 Fig. 1 . The protein
has a relatively low intrinsic ATPase activity, which
is NEM-sensitive and is contributed to in roughly
w xequal parts by each nucleotide binding site 17,20 .
All three domains are essential for NSF-dependent
w xintra-Golgi transport activity 17,21 .
NSF and Sec18p are members of a family of
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Fig. 1. Primary structures of NSF and a-SNAP. The domain
structures of NSF and a-SNAP are shown. The functional impor-
tance of each domain, where known, is indicated. Regions with a
high propensity to form coiled coils are indicated in black.
closely related proteins which have similar domain
w xstructures 19 . Interestingly, although most of these
proteins have quite diverse functions, at least one of
them is able to drive NSF-independent membrane
w xfusion 22 .
( )3. Soluble NSF Attachment Protein SNAP activ-
ity
Despite the abundance of NSF on Golgi mem-
branes, the protein is unable to bind to salt or carbon-
w xate-extracted membranes directly 23 . An assay for
factors which could mediate NSF binding to mem-
branes led to the purification from bovine brain cy-
tosol of three closely related proteins a-, b-, and
 4.g-Soluble NSF Attachment Proteins SNAPs of
molecular weights 35, 36, and 39 kDa, respectively
w x24 . All three proteins could support intra-Golgi
transport with efficiencies that reflected their abilities
w xto recruit NSF 24 . Only a- and g-SNAP are widely
expressed, with b-SNAP performing a brain-specific
w xfunction 25,26 . Some synergy is shown between a-
w xand g-SNAP 25 . Conservation appears restricted to
a-SNAP; the yeast SEC17 gene encodes a protein
with greatest homology to a-SNAP which can func-
tionally substitute for the mammalian protein, at least
w xin part 27 . A Drosophila homologue of a-SNAP
w xhas also been identified 14 . In common with
NSFrSec18p, a-SNAPrSec17p activity is impli-
cated in many membrane fusion events in addition to
intra-Golgi transport. These include homotypic fusion
w xbetween endosomal membranes 7 and between yeast
w xvacuoles 28 , as well as targeting of vesicles to the
w xcell surface 8 . Further evidence indicates that a-
SNAP may be an essential component of the regu-
lated secretory apparatus; recombinant SNAP pro-
teins stimulate catecholamine release from chromaf-
w xfin cells 29 , and injection of specific SNAP peptides
blocks neurotransmitter release from squid giant
w xsynapses 30 .
All three SNAPs are highly amphipathic. This is
reflected in their purification by hydrophobic interac-
tion chromatography and their uncommon ability to
bind to plastic surfaces despite their solubility in an
w xaqueous environment 24 . Each SNAP monomer
w x w xcontains three 25 or four 31 putative coiled-coil
forming domains potentially capable of interacting
 .with neighbouring molecules Fig. 1 .
4. NSF and SNAP form part of a multi-subunit
complex
Although NSF and a-SNAP do not interact in
solution, immobilisation of a-SNAP on plastic sur-
faces causes it to adopt a conformation that allows
w xinteraction with NSF 24,32 . The C terminal portion
w xof a-SNAP is required for this interaction 31 . Of
more biological relevance, the two proteins will also
bind each other tightly in the presence of detergent
w xextracts of membrane preparations 33 , indicating
that membrane-associated proteins will force a-SNAP
into a conformation that permits it to bind NSF. This
effect is specific, since NSF-SNAP interaction re-
quires ATP and is broken by conditions that allow
ATP hydrolysis. Furthermore, the complex contain-
ing a-SNAP and NSF has a defined stoichiometry
since it migrates on sedimentation gradients as a
single species with a sedimentation coefficient of 20S
w x33 . Functional analysis of NSF mutants has identi-
fied the regions of NSF that are critical for the 20S
w xcomplex assemblyrdisassembly cycle 17,21,34 and
have underlined the central importance that this parti-
cle plays in membrane transport.
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The D2 domain of NSF is crucial for oligomerisa-
tion of the protein since mutants lacking this domain
are monomeric, and when this domain is expressed
w xby itself it readily forms oligomers 17 . The N
terminal domain is essential for 20S complex forma-
tion since the D1D2 truncation mutant is unable to
form part of a complex. By itself, however, the N
domain is not incorporated into a complex. 20S
complexes can be formed inefficiently using either
ND1 or ND2 mutants, though their properties differ;
only the ND1 mutants are released from the complex
w xby conditions that allow ATP hydrolysis 21 . To-
gether, these results imply that the primary site for
NSF-complex interaction is via the N domain, but
 .that adjacent site s on the D1 domain are also needed.
Additionally, co-operativity between each NSF
monomer is required to obtain a high affinity interac-
tion. Presumably, communication between the N and
D1 domains couples complex assemblyrdisassembly
with the ATP hydrolytic cycle. Further circumstantial
evidence for this is that a monoclonal antibody which
recognises an epitope within the N domain stimulates
w xNSF-dependent ATP hydrolysis 20 and a similar
degree of stimulation is elicited by immobilised a-
w xSNAP 35 .
More refined mutational analysis provides further
information about the roles of ATP binding and
hydrolysis in NSF function. Site-directed mutagenesis
of the ATP binding site of domain D1 gives rise to
mutant proteins defective in either ATP binding
 266 .  329Lys to Ala; D1K-A or ATP hydrolysis Glu to
. w xGln 17,21 . Both mutants are almost completely
defective in intra-Golgi transport activity and act as
potent inhibitors of transport IC for D1K-As15750
. w xnM; IC for D1E-Qs9.4 nM 21 . Their inhibitory50
activities correlate with the ability of each mutant to
assemble into 20S complexes which do not disassem-
ble under conditions that allow ATP hydrolysis, with
the D1K-A mutant forming such complexes about 10
times less readily than the D1E-Q mutant. Essentially
similar results were obtained using a Lys266 to Met
w xmutation 34 . Together, these data provide the
strongest evidence for coupling between the turnover
of NSF-containing protein complexes and membrane
transport activity.
In contrast with the D1 domain, the role of ATP
binding and hydrolysis in the D2 domain is less clear.
Alterations in this ATP binding site can produce
mutants which are defective in ATP binding or hy-
drolysis, but still retain significant intra-Golgi trans-
w xport activity 17,21,34 .
( )5. SNAP receptors SNAREs
5.1. Isolation of neuronal SNAREs
The ability of NSF to couple its ATP hydrolytic
cycle to formation and disassembly of 20S complexes
has been exploited in an ingenious scheme for the
affinity isolation of other members of the complex
 . w xthat can act as SNAP receptors SNAREs 36 .
Complexes were formed by passing detergent ex-
tracts of membranes over a matrix containing immo-
bilised NSF in the presence of a-SNAP and EDTA-
ATP. After washing, the components of the complex
were eluted specifically under conditions that permit-
 .ted ATP hydrolysis Mg-ATP . When this procedure
was employed using brain membranes, three previ-
ously identified proteins synaptobrevin, syntaxin and
. 2qSNAP-25 that had been implicated in Ca -mediated
exocytosis of neurotransmitter at the nerve terminal
w xwere isolated 36 .
Synaptobrevin, or Vesicle-Associated Membrane
 .Protein VAMP was first identified as a component
w xof synaptic vesicles 37,38 . It was thus termed a
vesicle-associated- or v-SNARE by Rothman and
colleagues. It has an unusual membrane topology
 .Fig. 2 . Synaptobrevins I and II are integral mem-
brane proteins of about 13 kDa with their membrane
spanning domains close to their C termini, so that
most of the protein is exposed to the cytosol. The
w xcytosolic domain contains two distinct regions 39 .
At the extreme N terminus is a proline-rich domain
which ends in dibasic residues. This is followed by a
highly conserved domain which contains two se-
quences with high propensity to form amphipathic
 .helices a.a. 37–55; a.a. 51–88 . The region of con-
servation extends some way into the transmembrane
domain. Of the two helical regions, the second is
composed of heptad repeats, common to coiled coil
w xstructures 40 . Such structures are often identified as
regions that form strong interactions with neighbour-
ing proteins by virtue of alignment between helices.
The first helix is unusually hydrophobic and has
properties similar to those of fusion peptides found in
( )P.G. WoodmanrBiochimica et Biophysica Acta 1357 1997 155–172 159
w xviral envelope proteins 41 . On this basis it has been
proposed that synaptobrevin might contribute directly
to membrane fusion, whereby an induced change in
conformation of the second helical region leads to
w xexposure of the fusion peptide 42 .
Syntaxins I and II are isoforms of an integral
membrane protein of 35 kDa localised predominantly
w xto the presynaptic plasma membrane 43 , and thus
termed a target membrane-associated- or t-SNARE.
However, substantial amounts of the protein are also
found throughout the axonal plasma membrane and
w xassociated with recycling synaptic vesicles 44 . Syn-
w xtaxin is essential for synaptic function 45 . Like
synaptobrevin, the majority of the sequence of syn-
w xtaxin is cytoplasmically orientated 43 . At least three
regions of syntaxin have a high propensity to form
w xcoiled coils 46 , indicating potential sites for inter- or
 .intramolecular interactions Fig. 2 . Unlike synapto-
brevin and syntaxin, the other t-SNARE, SNAP-25,
 . w x25 kDa synaptosomal associated protein 47 does
not span the membrane bilayer. Instead, it relies on
palmitoylation, most probably on cysteine residues
near the centre of the molecule, for attachment to the
cytoplasmic face of the presynaptic plasma mem-
w xbrane 48,49 . SNAP-25 is characterised by three
w x regions with propensity to form coiled coils 42 Fig.
.2 .
5.2. E˝idence for in˝ol˝ement of SNAREs in neuro-
transmission
Independent evidence has identified the critical
role played by the three neuronal SNAREs in regu-
lated secretion, although other functions for each
SNARE, including axonal development, have been
w xpostulated 50,51 . Synthetic proline-rich peptides that
mimic the N-terminal domain of synaptobrevin II
potently inhibited neurotransmission when injected
w xinto presynaptic neurones 52 . Additionally, a pep-
tide from the C terminal domain of SNAP-25 blocked
w xcatecholamine release from chromaffin cells 53 and
syntaxin I peptides blocked regulated secretion in
w xPC12 cells 54 . However, the most compelling evi-
dence comes from the finding that all three SNAREs
collectively are specific substrates for the various
tetanus and botulinum clostridial neurotoxins that
cause rigid or flacid paralysis by profound inhibition
w xof neurotransmitter release 55–57 .
Clostridial neurotoxins are produced as precursor
w xpolypeptide chains of about 150 kDa 57 . These are
Fig. 2. Primary structures of neuronal SNAREs. The domain structures of mammalian synaptobrevin, syntaxin and SNAP-25 are shown.
Regions of each protein required for intra- or intermolecular interactions are indicated. Putative coiled coil domains are shown in black.
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cleaved to produce an H chain of 100 kDa which
remains linked to the L chain by an intermolecular
disulphide bond. Targeting to the neurone surface is
mediated by the H chain, which binds to specific
receptors. After internalisation, the activated L chain
is targeted to the cytosol. Here, each L chain exhibits
a potent and highly specific Zn2q-dependent endopro-
w xtease activity towards individual SNAREs 55–57 . It
is noteworthy that for each substrate where the cleav-
age site has been identified, cleavage occurs at a
position where a helical coil is predicted. This indi-
cates that proteolysis might interfere with the capac-
 .ity of the substrate to interact with other protein s .
Indeed, synaptobrevin and SNAP-25 fragments pro-
duced upon cleavage by tetanus toxin and botulinum
toxin A, respectively, are incorporated into SNARE
w xcomplexes of reduced stability 58,59 . Although the
molecular basis for the substrate specificity of each
protease is not fully understood, it is probable that
recognition is based on tertiary, rather than primary
structure, since synthetic peptides containing the
 w x.cleavage sites are relatively poor substrates see 60 .
Recent data indicate that SNAREs share common
motifs outside the toxin cleavage site, which act as
w xtoxin recognition sites 61,62 . These motifs, which
are capable of binding several toxins, form short
amphipathic helices possessing hydrophobic and neg-
atively charged faces. In the case of synaptobrevin,
the V1 motif is essential for cleavage by botulinum B
and G toxins, while the V2 motif is required for
w xtetanus toxin-induced cleavage 62 . The degree of
conservation of these regions testifies to their impor-
tance for normal SNARE function. Recent studies by
Kelly and co-workers have identified V1 as a region
with an important role in the targeting of synapto-
w xbrevin to synaptic vesicles 63 .
6. Interactions between SNAREs
Although SNAREs act as SNAP receptors, they
can also be co-immunoprecipitated in the absence of
w xa-SNAP and NSF 64 , indicating that they can form
 .complexes between each other directly see Fig. 2 . It
is generally believed that such 7S complexes are
preassembled to provide a template for SNAP and
NSF binding. Mutational analysis of recombinant
forms of each neuronal SNARE has led to the de-
scription of a complex whose stability is modulated
by NSF and SNAP. Several studies have shown that
the t-SNAREs syntaxin and SNAP-25 will interact
w xdirectly to form a stable binary complex 42,58,65,66 .
Interaction occurs via a complicated motif located
within the N terminal portion of SNAP-25 and via
the coiled coil region encoded by a.a. 199–243 of
w xsyntaxin 42 . Syntaxin will also bind synaptobrevin
w xdirectly, though with low affinity 58,66,67 . Binding
 .requires the same region on syntaxin a.a. 194–267
w xas that required for SNAP-25 binding 67 . Syntaxin
binding to synaptobrevin may be regulated by the
ability of the N and C terminal domains of syntaxin
w xto bind each other 67 and so affect availability of
the synaptobrevin-binding region. Direct binding of
moderate affinity between SNAP-25 and synapto-
brevin requires multiple domains on SNAP-25, with
at least the C terminal 9 a.a. those cleaved by
. w xbotulinum toxin A essential 42 . Though binding of
synaptobrevin to either t-SNARE is not strong,
SNAP-25 greatly enhances interaction between syn-
w xtaxin and synaptobrevin 58,66 . Therefore, distinct
binary interactions give rise to a ternary complex of
considerable stability, as evidenced by the resistance
w xof the 7S complex to dissolution in SDS 58 .
7. a-SNAP binds to SNARE complexes
Collected evidence supports the view that the 7S
complex acts as a scaffold for SNAP binding see
.Fig. 2 , and that subsequent ATP hydrolysis by NSF
causes complex disassembly by inducing conforma-
 . tional changes in component s of the complex Fig.
.3 . Interaction between a-SNAP and individual
SNAREs is not strong; SNAP-synaptobrevin binding
w xcan not be detected 68,69 , while a-SNAP-SNAP-
25rsyntaxin binding to either the individual or com-
.plexed t-SNAREs is of low or moderate affinity
w x68–70 . However, complexes between syntaxin and
 .synaptobrevin which are stabilised by SNAP-25
w xwill bind two a-SNAP molecules tightly 68,69 and
an additional SNAP binding site is generated within
w xthe ternary complex 68 . Therefore, complex forma-
tion promotes SNAP binding both by providing more
sites and by increasing the affinity of existing sites.
Binding to a-SNAP requires the same domain of
syntaxin as that required for syntaxin-synaptobrevin
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w xor syntaxin-SNAP-25 binding 68,70 . Additionally,
the region of SNAP-25 which mediates syntaxin
w xbinding also binds a-SNAP 68 . Multiple domains
of a-SNAP are important for its interaction with
w xsyntaxin 31,68,70 .
Binding of a-SNAP allows recruitment of NSF to
the complex. Subsequent NSF-dependent ATP hydro-
lysis breaks the complex and leads to release of free
NSF, synaptobrevin, SNAP-25 and a-SNAP from
w xsyntaxin 64,68 . It has been demonstrated that NSF-
dependent ATP hydrolysis will drive a conforma-
tional change in syntaxin that releases a-SNAP and
w xsynaptobrevin 70 . Synaptobrevin will not re-bind
syntaxin for some time, indicating that the change of
conformation is long-lived. The N-terminal domain
of syntaxin is essential for the disassembly reaction
w x65,68 , perhaps indicating that ATP hydrolysis drives
w xsyntaxin self-association 70 .
Fig. 3. Pathway of 20S complex assembly and disassembly. Complex assembly begins with association between v-SNAREs and
t-SNAREs. This may occur upon vesicle-target membrane docking, or take place between SNAREs within the same bilayer. The 7S
SNARE complex acts as a scaffold for recruitment of a-SNAP, with a probable stoichiometry of 3 SNAP molecules per complex. This is
followed by binding of trimeric NSF. Subsequent ATP hydrolysis leads to disassembly of the complex and a conformational change in at
least one SNARE molecule, thus preventing complex reassembly. According to the SNARE hypothesis, such conformational change is
coupled directly to membrane fusion. In other models, ATP hydrolysis serves to ‘activate’ SNAREs prior to docking, or perhaps to
disentangle SNARE complexes formed after docking to allow multiple rounds of transport.
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8. Interaction of SNAREs with other proteins
An abundance of evidence is consistent with a role
for the 7S complex as a component of a membrane
transport machinery. However, interactions of neu-
ronal SNAREs are not confined to partners within
this complex, as a variety of additional binding part-
ners have been identified. It has been postulated that
such interactions modulate the ability of SNAREs to
bind each other and therefore contribute indirectly to
controlling membrane fusion. Additionally, such in-
teractions may play independent roles in the fusion
reaction. Several of these interactions are regulated
by calcium ions, reflecting the fact that fusion of
synaptic vesicles with the presynaptic membrane is
coupled to calcium influx.
8.1. Synaptophysin
Synaptophysin is a prominent synaptic vesicle-as-
sociated protein with 4 transmembrane domains. It
has the ability to form channels in membranes, lead-
ing to suggestions that it might contribute to forma-
w xtion of a fusion pore 71 . Synaptophysin co-im-
w xmunoprecipitates with synaptobrevin II 72,73 and
additional information has shown that this complex
also contains subunits of the vacuolar proton pump
w x74 . The two proteins can be cross-linked on the
synaptic vesicle membrane, indicating a direct inter-
action within the membrane of the pre-docked vesicle
w x72,73,75 . Binding requires the N terminal proline-
w xrich region of synaptobrevin II 75 . Binding of
synaptobrevin II to synaptophysin or t-SNAREs is
w xmutually exclusive 73,74 , suggesting that synapto-
physin might regulate formation of SNARE com-
plexes or vice versa. In fact, synaptobrevin II can be
isolated bound either to synaptophysin or to syn-
taxinrSNAP-25, depending upon whether membrane
w xextracts are freeze-thawed 74 . Thus, freeze-thawing
may mimic actions of effectors that shift the confor-
mation of synaptobrevin to allow SNARE complex
assembly.
8.2. nSec1
nSec1rmunc18rrbSec1 is a neuronal homologue
of the yeast SEC1 gene product, which is essential
w xfor secretion in yeast 76 , and the C. elegans gene
w xproduct unc18, required for neurotransmission 77 .
The protein is hydrophilic, though a large pool is
w xlocalised to the axonal plasma membrane 78,79 . A
number of studies have demonstrated physical inter-
w xaction between nSec1 and syntaxin 78,80,81 , al-
though the majority of nSec1 within the axon remains
w xunbound 79 . Interaction between syntaxin and nSec1
w xor SNAREs is mutually exclusive 66,78,81 . The
general view, therefore, is that nSec1 is a negative
regulator of SNARE complex formation and of mem-
brane fusion. However, genetic studies in yeast sup-
port the idea that Sec1p is a positive regulator of
w xexocytosis 76 . It could be argued, therefore, that
nSec1 binding may be an essential step in the activa-
tion of syntaxin. Regulation of SNARE complex
formation by protein phosphorylation is suggested by
the finding that nSec1 is phosphorylated in vitro by
protein kinase C and so prevented from binding to
w xsyntaxin 82 .
8.3. Calcium channels
Synaptic vesicle fusion is triggered within a mil-
lisecond of calcium entry, so it is significant to find
evidence of interactions between components of the
neuronal SNARE complex and voltage-gated Ca2q
channels. At present there is much debate as to
whether Ca2q entry from a single or multiple chan-
nels are required for fusion of an individual vesicle
 w x.see for example 83 . In any event, a full description
of these interactions are likely to have profound
implications for understanding the molecular basis
for Ca2q-induced fusion. Binding was first demon-
w xstrated by Scheller and colleagues 43 , who found
that syntaxin co-immunoprecipitated with N-type
Ca2q channels. Further characterisation identified
 .synaptotagmin see below and the a-latrotoxin re-
 .ceptor neurexin as additional members of the com-
w xplex 84 . More recently synaptobrevin and SNAP-25
w xwere added to this list 85 , though the presence of
synaptobrevin has not been detected by all groups
w x84 . It is probable that these SNAREs associate with
the channel by virtue of their interactions with syn-
w x w xtaxin 86 , which binds directly to the channel 87 .
Other studies have shown that the SNARE complexes
also associate with PrQ type Ca2q channels in con-
w xjunction with synaptotagmin 88 . Thus, at least a
subset of the neuronal SNAREs preassembles adja-
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cent to presynaptic Ca2q channels, pointing towards
the molecular basis for fast coupling between Ca2q
w xentry and synaptic vesicle fusion 85 . Conversely,
syntaxin negatively regulates Ca2q channel activation
when the proteins are co-expressed in Xenopus
w xoocytes 89,90 . The implications of channel regula-
tion by syntaxin are not clear. It has been postulated
that the principal role of such regulation could be to
contain a Ca2q flux within a microdomain close to a
w xdocked vesicle 90 . Alternatively, it may prevent
inappropriate Ca2q fluxes occurring at channels that
w xare not linked to docked vesicles 89 .
8.4. Synaptotagmin
Synaptotagmin was identified as a 65 kDa glyco-
w xprotein of the synaptic vesicle 91 . Its cytoplasmic
sequence contains two domains similar to the C2
2q w xregion of Ca -dependent protein kinase C 92 . These
bind Ca2q ions in a co-operative and phospholipid-
w xdependent manner 93 . More recent studies have
shown that synaptotagmin is palmitoylated close to
w xthe transmembrane domain 49,94 and acts as a
w xreceptor for polyinositol phosphates 95 . As with
other components of the neurosecretory apparatus,
several brain-specific isoforms of synaptotagmin are
w xfound 96 . Numerous genetic studies have identified
synaptotagmin I as an essential component in Ca2q-
 . wdependent evoked neurotransmitter release 97–
x100 . In contrast, synaptotagmin-deficient mutants
have unaltered or increased rates of spontaneous
w xtransmission 98–100 . More recent work has shown
that synaptotagmin I mutant mice are defective in fast
neurotransmitter release, but maintain a second
Ca2q-dependent slower phase, suggesting that multi-
2q w xple Ca sensors act at the synapse 101 . There is
much debate as to the precise role that synaptotagmin
plays. On the one hand, it has been argued that
synaptotagmin plays an essential role in the promo-
2q w xtion of Ca -dependent membrane fusion 102 . Con-
versely, evidence has been interpreted to suggest that
synaptotagmin acts as a fusion clamp which prevents
w xspontaneous neurotransmitter release 64,99 . The
clamp is removed by the calcium influx that is trig-
gered by membrane depolarisation. In part, this un-
certainty over function may be a reflection of the fact
that synaptotagmin is also implicated in endocytosis
w x103 , so that its activities during the synaptic vesicle
w xcycle are complex 104 . It is quite possible, how-
ever, that synaptotagmin both promotes vesicle dock-
w xing and inhibits spontaneous release 100 .
Syntaxin binding to synaptotagmin relies on the
 .same domain of the protein a.a. 194-288 as that
required for its interaction with partner SNAREs and
w xa-SNAP 105 . In fact, efficient binding was ob-
served between synatoptagmin and a.a. 220-266 of
w x 2qsyntaxin 106 . Binding is strongly Ca -dependent,
though the details of the Ca2q-dependence are com-
plex and appear to differ according to how each
component is presented in the binding assay
w x 2q105,106 . Together, the results indicate that Ca
has differential effects on synaptotagmin conforma-
 . tion when present at low 1–3 mM or higher 100
.mM concentrations. This scenario could give rise to
specific intermediates in synaptotagmin-dependent
processes as local calcium concentrations increase
after activation of voltage-sensitive channels. A fur-
ther calcium-dependent conformational change in
synaptotagmin causes the protein to self-associate via
2q w xits second C2 domain at ;3 mM Ca 107,108 .
Multivalency may induce co-operative binding of
synaptotagmin to syntaxin at higher Ca2q concentra-
tions, and thus contribute to the co-operative effect of
Ca2q ions on neurotransmitter release. Interaction
between synaptotagmin and syntaxin is broken upon
w xaddition of a-SNAP 64 . However, the significance
of this in the context of Ca2q-dependent fusion is
unclear given that displacement does not require Ca2q
ions. In a second Ca2q-independent interaction,
synaptotagmin will bind b-SNAP, but not a-SNAP
w x26 . This finding is the first indication of a
neuronal-specific role for b-SNAP.
Although synaptotagmin is a calcium sensor, non-
neuronal homologues of synaptotagmin have been
identified which differ in their sensitivities to Ca2q
w x109 . Additionally, synaptotagmin interacts with sev-
eral other proteins in a Ca2q-independent manner
w x110 . Therefore, this family of proteins is likely to
play a general role in vesicular transport.
8.5. Complexins
Complexins I and II were identified recently by
virtue of their association with neuronal SNARE
w xcomplexes 111 . However, they are expressed ubiq-
w xuitously 111 . Although their function is not known,
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evidence suggests they regulate the stability of 20S
complexes. Firstly, they bind stoichiometrically with
syntaxin I and the affinity of this interaction is in-
creased dramatically when syntaxin is incorporated
into a SNARE complex. Secondly, complexins com-
pete with a-SNAP for binding to syntaxin.
9. Conservation of SNAREs
NSF and a-SNAP have widespread involvement
in membrane transport, yet bind proteins required for
the highly specialised process of Ca2q-mediated neu-
rotransmission. It is clear, however, that neuronal
SNAREs or their homologues are widely distributed
between tissues, and are conserved through evolution.
SNAREs are therefore general mediators of mem-
brane targeting. In contrast to NSF and a-SNAP,
many distinct isoforms of each SNARE exist, which
have discrete intracellular localisations. On this basis
it is believed that SNAREs and their associated pro-
teins contribute to the specificity of membrane trans-
port.
9.1. ˝-SNAREs
Perhaps not surprisingly, synaptobrevin II is asso-
ciated with dense core secretory granules of neuroen-
w xdocrine cells 112 , and synaptobrevin has been lo-
calised to a vesicle population containing the glucose
w xtransporter Glut4 in adipocytes 113 . This transporter
is stored in vesicles that are in some ways analagous
to synaptic vesicles and is delivered to the adipocyte
cell surface in response to insulin. Similarly, synapto-
brevin is found in endosome fractions of kidney cells
containing anti-diuretic hormone-regulated water
w xchannels 114 . However, the distribution of synapto-
brevin I and II is even more widespread, since RNA
transcripts and proteins have been detected in skeletal
w x w xmuscle 115,116 and many other tissues 117 . A
w xnovel isoform of synaptobrevin, cellubrevin 118 , is
also widely expressed. Its cellular localisation is simi-
lar to the transferrin receptor, implicating it in trans-
port events of the endocytic pathway. Functional
studies suggest a role in vesicular recycling to the
w xplasma membrane 119 , rather than endosomal tar-
w xgeting 120 . Other, more distant members of the
synaptobrevin family exist in mammalian cells; a
novel v-SNARE is associated with the Golgi complex
and participates in ER-Golgi and intra-Golgi trans-
w xport 121,122 .
9.2. t-SNAREs
In addition to the neuronal-specific syntaxin 1A
and 1B, other mammalian isoforms of syntaxin are
w xdistributed widely in mammalian tissues 54 . For
example, syntaxin 4 has been implicated in insulin-
dependent translocation of Glut 4-containing trans-
w xporters to the cell surface of adipocytes 123 . Al-
though several syntaxin isoforms are localised pri-
marily on the cell surface, syntaxin 5 is associated
w xwith the cis face of the Golgi complex 124 and is
w xrequired for ER-Golgi transport 125 . Another syn-
taxin, syntaxin 6, has been localised to the Golgi
region of cells by immunofluorescence microscopy
w x126 . Biochemical data also indicate selective func-
tions for the syntaxins; syntaxins 1 and 4, but not 2
w xand 3, bind to synaptobrevin 67 .
Although predominantly expressed in the brain,
w xSNAP-25 is also expressed in endocrine cells 127 as
well as to some extent in adipose tissue and skeletal
w xmuscle 128 . It is expressed at high levels in pancre-
atic B cells where it is involved in insulin release
w xfrom large dense core granules 129 . A related pro-
tein, SNAP-23, is also expressed in non-neuronal
w xcells 130 .
9.3. Yeast SNAREs
In yeast, a similar array of SNARE isoforms has
been identified. In many cases, genetic or biochemi-
cal analyses show selective involvement of SNAREs
in individual transport reactions, though some
SNAREs may be required for more than one trans-
w xport pathway 131 . These findings support the argu-
ment that SNAREs contribute to the specificity of
transport for exocytic transport, at least, there is
strong evidence for involvement of an additional
w x.protein complex 132 . Additionally, for several
transport reactions more than one essential v-SNARE
andror t-SNARE has been identified. Several of
these can be found together in 20S complexes formed
w xin vivo under appropriate conditions 133 . Therefore,
SNAREs may act in concert to ensure a high degree
of fidelity of transport. The synaptobrevin homo-
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w xlogues Snc1p and Snc2p 134 and the syntaxin ho-
w xmologues Sso1p and Sso2p 135 are required for
delivery of proteins from the Golgi complex to the
cell-surface. Sec22prSly2p, Bet1prSly12p and
Bos1p are synaptobrevin homologues required for
w xER-Golgi transport in yeast 136–138 , while another
synaptobrevin homologue, Sft1p, plays a role in in-
w xtra-Golgi transport 131 . The syntaxin 5 homologue
w xSed5p 139 may be important for two transport
reactions; it has been shown to be essential for
ER-Golgi transport, yet Sed5 interacts genetically
with Sft1, implying a role for its gene product in
w xintra-Golgi transport 131 . Sorting of proteins to the
w xvacuole requires another t-SNARE, Pep12p 140 . A
SNAP-25 homologue, Sec9p, acts during transport of
w xpost-Golgi vesicles and interacts with Sso1p 141
w xand Snc1prSnc2p 142 . Yeast SNAREs exhibit a
significant degree of homology to their mammalian
counterparts, with the level of homology generally
greatest between those SNAREs which take part in
w xequivalent transport steps 143 .
10. Regulation of SNARE function
A number of proteins interact with neuronal
 .SNAREs see above and in several cases these pro-
teins, or their homologues, are widely expressed and
conserved. Sec1p was originally identified as a pro-
tein essential for Golgi-cell surface transport in yeast
w x76 , and a sec1 mutant is suppressed by overexpress-
w xing the SSO1 or SSO2 genes 135 . Additional yeast
homologues have been identified which function in
 . w xER-Golgi transport Sly1p 136 and vacuolar sort-
 w x w x.ing Vps45p 144 and Vps33prSlp1p 145 . A
w xnon-neuronal isoform of nSec1 has been found 146 ,
w xas well as a mammalian homologue of Sly1p 147 .
Therefore, the members of the Sec1 family are likely
to be compartment-specific markers. Genetic and
physical interactions suggest that members of the
Sec1p family affect syntaxin function, though it is not
clear whether they act as negative or positive regula-
tors, or both according to conditions.
The Rab and Ypt family members are low molecu-
lar weight GTP binding proteins that are essential for
membrane transport in mammalian and yeast cells,
respectively. Their activities have been widely docu-
w xmented 148,149 . At present it is not clear how their
function relates to the activities of SNAP and NSF.
Current models propose that RabrYpt members posi-
tively regulate the formation of 20S complexes and
are therefore required upstream of NSF and SNAP in
transport reactions. Genetic interactions in yeast ap-
pear to favour these models, and additional support-
ing evidence has been gained from biochemical stud-
w xies using different genetic backgrounds 133,141,150 .
Uso1p, a yeast homologue of a ubiquitous cytosolic
protein required for fusion, also plays a role in this
w xactivation process 151 . A recent report suggested
that Ypt7p, which is required for homotypic fusion
between yeast vacuoles, acts after Sec17prSec18p
w x28 . This interpretation was based primarily on ex-
periments in which fusion incubations were arrested
at the Sec18p-dependent step by addition of anti-
Sec18p antibodies. Fusion activity could be restored
by addition of exogenous Sec18p, yet remained sensi-
tive to inhibitors of Ypt7p function. However, it
could be argued that the exogenous Sec18p required
Ypt7p for its activation. RabrYpt proteins are lo-
calised to specific compartments and it seems likely
that they contribute to the specificity of membrane
w xfusion 149 .
11. Current models for NSFrSNAPrSNARE
function during membrane fusion
Models for membrane fusion must take into ac-
count the characteristics of the fusion reaction. Unfor-
tunately, only fusion reactions at the cell surface have
been measured electrophysiologically and these are
fast, regulated secretion events that follow specific
stimuli. Under these conditions the transport vesicle
may already be docked and perhaps primed for fu-
sion. Several general observations apply, however
which are probably relevant for other membrane fu-
sion events given the conservation of function illus-
w xtrated above 152 . Firstly, membrane fusion is ex-
tremely rapid, occurring within fractions of a mil-
w xlisecond of calcium influx 153 . Secondly, fusion
begins with formation of a relatively small fusion
pore with a conductance of less than 150 pS, of the
same order of size as a proteinaceous ion channel
w x154 . Slower expansion of the pore follows. Thirdly,
membrane fusion, at least at early points, is re-
versible. In fact, it has been argued that release of
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neurotransmitter at certain levels of stimulation could
be accounted for to a significant extent by the open-
ing and re-closing of a fusion pore sufficiently large
to allow release of only low molecular weight content
w xmolecules 155 .
There is now considerable evidence to support the
scheme for SNARE complex assemblyrdisassembly
outlined in Fig. 3. Little is understood about how
such a reaction contributes to membrane fusion,
though a variety of models have been proposed. The
degree of discrepancy between each model is proba-
bly a reflection of the limitations, as well as suc-
cesses, of different experimental systems. For exam-
ple, in vitro binding assays have been of great impor-
tance in defining complex intermolecular interactions,
but tell us nothing about the temporal order that each
binding event takes before, or perhaps after, fusion
has occurred. Likewise, genetic studies have been
used to identify novel proteins and to provide evi-
dence for specific interactions, but by themselves say
little about the role played by these proteins in fusion.
They may also be prone to misinterpretation due to
induction of compensating pathways or the role of a
protein in more than one step of a cycling pathway.
The model that has received most attention is the
w xSNARE hypothesis 156 . This therefore serves as a
convenient starting point to discuss current views on
membrane fusion.
The SNARE hypothesis was formed on the basis
of the interaction of NSF and a-SNAP with the
w xneuronal v- and t-SNAREs 36,156 . It has two com-
ponents. Firstly, it is proposed that v- and t-SNAREs
are markers for specific sets of transport vesicles and
compartments within the cell. Therefore, the speci-
ficity of membrane fusion is derived primarily from
the interactions between appropriate v- and t-SNAREs
at the point of membrane recognition. Limited evi-
dence from both yeast and mammalian systems is
generally consistent with such a model. Several forms
of each SNARE are expressed in each cell. Of those
identified, all have compartment-specific localisa-
tions. SNAREs contain coiled coil motifs which par-
ticipate in molecular recognition, and available evi-
dence supports the notion that v-SNARErt-SNARE
interactions are specific. However, there is still no
direct evidence that v-SNARErt-SNARE interactions
play a primary role in vesicle docking. Additionally,
there are indications that additional complexities ex-
ist. Firstly, some SNAREs appear to take part in
more than one transport reaction, so additional con-
straints would be required to ensure accurate trans-
w xport 131 . Secondly, several studies have shown that
transport vesicles contain t-SNAREs as well as v-
w xSNAREs 44,157,158 . Therefore, any mechanism for
vesicle docking based on v-SNARErt-SNARE inter-
action must ensure that vesicle-associated t-SNAREs
remain inactive. There must also be a mechanism to
regulate v-SNAREs recycling back to the donor com-
partment. This might be achieved via the activity of
interacting proteins such as Sec1p or RabrYpt family
w xmembers 156 . Thirdly, Drosophila strains lacking
synaptobrevin or syntaxin contain a normal comple-
ment of docked synaptic vesicles at their presynaptic
junctions despite gross impairment of synaptic vesi-
w xcle fusion 159 . These findings are reminiscent of
those of Hunt and co-workers who found that tetanus
toxin blocked fusion, but not docking, of synaptic
w xvesicles 160 . At a superficial level both reports are
consistent with a purely post-docking role for synap-
tobrevin, although it could be argued in each case
that docking is impaired but the defect is not seen
because the consumption of this pool of vesicles is
also impaired. However, these results could indicate,
at the least, that vesicle docking can be mediated by
pathways in addition to the t-SNARErv-SNARE in-
teraction.
The second component of the SNARE hypothesis
deals with the mechanism of membrane fusion. It is
proposed that NSF and a-SNAP contribute directly
to membrane fusion by coupling the energy of ATP
w xhydrolysis to membrane rearrangement 64,156 . How
this is achieved is not clear, but one possible mecha-
nism is by inducing such a gross conformational
change in the docked SNARE complex that lipid
w xrearrangement follows 64 . In this context the possi-
bility that synaptobrevin contains a cryptic fusion
w xpeptide 42 is interesting. The SNARE hypothesis
provides an attractive model to account for mem-
brane fusion, not least because membrane fusion
would be coupled to disassembly of the fusion appa-
w x ratus 33 and release of essential co-factors NSF
.and SNAPs into the cytosol. Such transient interac-
tion of fusogenic proteins with membranes would
minimise the risk of inappropriate fusion occurring.
Despite this, the evidence that SNARE rearrange-
ment coupled to NSF-dependent ATP hydrolysis
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drives membrane fusion directly is not so far com-
pelling. The predictions of such a model do not fit
well with measurements of synaptic vesicle fusion.
Firstly, it is difficult to imagine that such a conforma-
tional change driven by ATP hydrolysis would allow
for formation of a rapidly reversible fusion pore.
w xSecondly, as pointed out by others 161,162 , the
speed of synaptic vesicle fusion is 3–4 orders of
magnitude faster than that of NSF-dependent ATP
hydrolysis. Thirdly, there is no evidence that fusion
of docked vesicles requires addition of ATP, although
it could be argued that fusion utilises a pool of
w xtightly-bound nucleotide 161 . Fourthly, fusion at the
synapse is tightly coupled to Ca2q entry and synapto-
tagmin function, yet synaptotagmin release from 20S
2q w xcomplexes is Ca -independent 64 .
Much of the evidence for or against the SNARE
hypothesis in other cellular contexts is equivocal,
reflecting the fact that it is collected from several
different experimental systems. At the very least,
though, collated evidence points towards refinement
of the basic model. A central prediction based on the
hypothesis is that interaction of NSF and SNAPs with
membranes must be transient at the point of vesicle
w xdocking 33,156 . Therefore, these proteins should
not be components of transport vesicles. Consistent
with this, NSF could not be detected in COPI-coated
transport vesicles formed during in vitro intra-Golgi
transport reactions. Nor was it associated with coated
w xbuds on Golgi membranes 163 . Additionally, NSF
was not reported to associate with COPII-coated
transport vesicles made from in vitro incubation of
w xyeast ER 164 . On the other hand, NSF is associated
w xwith pre-docked synaptic vesicles 165 and is also
found bound to clathrin-coated endocytic vesicles
w x158 . Moreover, isolated membrane preparations
which are unlikely to contain significant numbers of
.docked vesicles are rich in NSF. In these and other
membranes NSF is bound by interactions that differ
from those that bind it to 20S fusion complexes, since
the protein is not released by conditions that favour
w xATP hydrolysis 158 . The exception appears to be
w xGolgi preparations 2,166 , perhaps because they con-
w xtain extensive areas of docked membranes 33,156 . It
seems likely, therefore, that if the 20S complex con-
tributes to fusion, at least some of its soluble compo-
nents move from neighbouring sites within the mem-
brane rather than from the cytosol.
Evidence about the kinetics of NSF involvement in
transport is also equivocal, but points generally to-
wards a prefusion role. Treatment of intra-Golgi
transport assays with NEM causes accumulation of
docked transport vesicles, indicating a post-docking
w xrole for NSF 3 . However, it is impossible to distin-
guish between transport vesicles docked at the target
membrane and those that have been impaired in their
release from the donor membrane. Conversely, in
yeast, sec18-1 mutants accumulate free transport
vesicles suggesting a role for NSF in vesicle docking
w x167 , but this result does not rule out that the pri-
mary consequence of the defect is a block in fusion
of docked vesicles. Sensitivity of intra-Golgi trans-
port reactions to the dominant hydrolysis mutant of
NSF is observed upon pre-incubation of donor mem-
branes, from which transport membranes bud, with
the mutant. However, pre-incubation of acceptor
membranes with the mutant did not affect transport
w xactivity 34 . Wild-type NSF can prevent inhibition
by a dominant mutant, but only when added early
w xduring the transport reaction 34 . Moreover, pre-in-
cubation of donor membranes alone under transport
conditions renders the transport reaction insensitive
w xto subsequent addition of NEM 168 . Collectively,
these data have been interpreted as showing that NSF
acts early during transport, though they may simply
define the point at which NSF attachment to mem-
brane occurs. Similarly, endosomal membrane fusion
is NSF-dependent, but the requirement may be ob-
scured when sufficient NSF to drive fusion is at-
w xtached to pre-docked membranes 7 . Sensitivity of
endosomal fusion to NSF dominant mutants is also
short-lived, implying that NSF is attached to mem-
w xbranes early in the reaction 169 . Vacuolar fusion in
yeast is sensitive to anti-Sec18p antibodies only at
w xearly stages during the fusion reaction 28 , confirm-
ing earlier suggestions that at least some NSF-depen-
dent partial reactions occur prior to docking during
w xhomotypic fusion 7 .
Examination of the role of a-SNAP during fusion
also points towards an early recruitment. Firstly,
exogenous SNAPs can enhance fusion of cate-
cholamine-containing vesicles with the plasma mem-
brane in chromaffin cells, but the SNAP requirement
seems to occur earlier than the Ca2q-mediated step in
w xfusion 170 . Secondly, a kinetic block of intra-Golgi
transport using primaquine as a reversible inhibitor of
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transport vesicle budding implicated a-SNAP as an
w x essential component of vesicle production 168 . This
study, however, does not preclude an additional role
.for a-SNAP in vesicle fusion . Thirdly, examination
of homotypic fusion in yeast reveals that Sec17p is
released from membranes in an ATP-dependent fash-
w xion prior to membrane docking 28 . Although it is
possible that a low level of membrane-bound Sec17p
is capable of driving the fusion reaction, this observa-
tion provides the most telling evidence against the
involvement of Sec17pra-SNAP in membrane fu-
sion itself.
Together, these observations point loosely towards
an involvement of NSFrSNAP-dependent ATP hy-
drolysis in a priming event that is one of perhaps
several reactions necessary to render the membranes
w xfusion-competent 170,171 . Later conformational
changes in proteins, linked to Ca2q entry where
appropriate, would also be required for fusion. The
nature of such a priming reaction, and the identity of
 .the fusogenic protein s activated by it, remain a
mystery. For example, it has been proposed that
NSFrSNAPs activate SNARE complexes on the
vesicle membrane by inducing conformational
w xchanges that render SNAREs fusion-competent 161 .
Equally, however, the primary activity of NSFrSNAP
might be to act post-fusion, to break up a SNARE
complex formed during the fusion event itself and
thus allow recycling of SNAREs. Finally, there is
still no overwhelming evidence to exclude the reverse
scenario; that the primary function of SNAREs is to
activate either NSF andror SNAPs in an ATP-depen-
dent reaction, so that these may act in some way as
the fusogenic proteins themselves.
Distinction between these models will require fur-
ther investigation into the partial reactions of NSF-
dependent ATP hydrolysis, since this lies at the heart
of the function of the 20S complex. As an analogy,
examination of the GTPase cycle of Rab proteins has
led to surprising discoveries about their role in fu-
sion. For Rab5 at least, the GTP-bound form of the
w xprotein is activated for fusion 172 , and effectors of
Rab5 function modify the GTPase activity of Rab5 so
as to modulate the proportion of Rab5 on a mem-
w xbrane that is active 173 . In this sense, Rab5 is
believed to act as a timer for the fusion reaction.
Likewise, NSF and SNAPs may act as transient
activators of SNARE complexes. The duration of
SNARE activation could be governed by the rate of
ATP hydrolysis, as well as by direct effectors of
SNARE function. Regulation of fusion by at least
two independent timing mechanisms would provide
an effective but flexible means to control fusion
activity. Moreover, since fusion would be governed
 .by the probability of activation of perhaps several
components, rather than absolute concentrations of
SNAREs, such a mechanism could accommodate for
the recycling of SNAREs through ‘inappropriate’
compartments, as well as for occasional mis-targeting
events.
In summary, evidence from a host of experimental
systems points to the central importance that NSF
and SNAPs play in membrane transport. A complex
between NSF, SNAP, and membrane receptors
 .SNAREs is an essential intermediate in many trans-
port reactions. However, the exact roles played by
these proteins in each transport step remains a point
of conjecture. At this time it is important to rule
nothing out, and to be circumspect when ruling any-
thing in.
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